Guideline No. 423: Female Genital Cosmetic Surgery and Procedures.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2022 Vol.44(2) p. 204-214.e1

Shaw D, Allen L, Chan C, Kives S, Popadiuk C, Robertson D, Shapiro J

Abstract

[OBJECTIVE] To provide Canadian surgeons and other providers who offer female genital cosmetic surgery (FGCS) and procedures, and their referring practitioners, with evidence-based direction in response to increasing requests for, and availability of, vaginal and vulvar surgeries and procedures that fall outside the traditional realm of medically indicated reconstructions.

[TARGET POPULATION] Women of all ages seeking FGCS or procedures.

[BENEFITS, HARMS, AND COSTS] Health care providers play an important role in educating women about their anatomy and helping them appreciate individual variations. Most women requesting FGCS and procedures have normal genitalia, and up to 87% are reassured by counselling. At this time, due to lack of rigorous clinical or scientific evidence of short- and long-term efficacy and safety, FGCS and procedures for non-medical indications cannot be supported. FGCS and procedures are typically provided in the private sector, where costs are borne by the patient.

[EVIDENCE] Literature was retrieved through searches of MEDLINE, Scopus, and The Cochrane Library using appropriate controlled vocabulary and keywords. The selected search terms represented keywords for FGCS (labiaplasty, surgery, vaginal laser therapy, laser vaginal tightening, vaginal laser, vaginal rejuvenation, vaginal relaxation syndrome, hymenoplasty, vaginal cosmetic procedures) combined with female genital counselling, consent, satisfaction, follow-up, adolescent, and body dysmorphic or body dysmorphia. The search was restricted to publications after 2012 in order to update the literature since the previous guideline on this topic. Results were restricted to systematic reviews, randomized controlled trials, and observational studies. Studies were restricted to those involving humans, and no language restrictions were applied. The search was completed on May 20, 2020, and updated on November 10, 2020.

[VALIDATION METHODS] The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See online Appendix A (Tables A1 for definitions and A2 for interpretations of strong and weak recommendations).

[INTENDED AUDIENCE] Gynaecologists, primary care providers, surgeons performing FGCS and/or procedures.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 genital scispacy 1
해부 vaginal scispacy 1
해부 vulvar scispacy 1
해부 body scispacy 1
합병증 vaginal scispacy 1
약물 [OBJECTIVE] scispacy 1
약물 [TARGET POPULATION] Women scispacy 1
약물 [VALIDATION METHODS] The scispacy 1
약물 [INTENDED AUDIENCE] scispacy 1
질환 vulvar C0042993
Vulva
scispacy 1
질환 vaginal relaxation syndrome scispacy 1
질환 vaginal cosmetic scispacy 1
기타 women scispacy 1
기타 genitalia scispacy 1
기타 patient scispacy 1
기타 humans scispacy 1

MeSH Terms

Adolescent; Canada; Female; Gynecologic Surgical Procedures; Gynecology; Humans; Surgery, Plastic; Vagina